Utility of Ga-68 DOTA PET-CT in Neuroendocrine Tumours

Neuroendocrine tumours are a diverse group of relatively rare cancers, with a reported incidence of 9 cases per 100,000 people in 2015.

Recently there have been major advances in their diagnosis, staging and treatment.  The possibility of multiple options to investigate and treat a diverse range of rare tumours represents a challenge for all members of the MDT, not least the radiologist.

The course aims to provide an overview of the use of Ga-68 DOTA PET-CT in the diagnosis and treatment of patients with neuroendocrine tumours.

It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorial.

Suitable for radiologists and nuclear medicine physicians who intend to train to report on the utility of Ga-68 DOTA PET-CT neuroendocrine tumour imaging and molecular radiotherapy, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.